World Journal of Dentistry

Register      Login

VOLUME 12 , ISSUE 6 ( November-December, 2021 ) > List of Articles

ORIGINAL RESEARCH

Evaluation of Ofloxacin and Ornidazole as an Adjunct to Scaling and Root Planing in the Treatment of Generalized Chronic Periodontitis: A Randomized Clinical Study

Athira K Chermmal, MB Harsha, Marenahalli R Vivekananda

Keywords : Chronic periodontitis, Ofloxacin, Ornidazole, Root planing, Scaling

Citation Information : Chermmal AK, Harsha M, Vivekananda MR. Evaluation of Ofloxacin and Ornidazole as an Adjunct to Scaling and Root Planing in the Treatment of Generalized Chronic Periodontitis: A Randomized Clinical Study. World J Dent 2021; 12 (6):485-491.

DOI: 10.5005/jp-journals-10015-1881

License: CC BY-NC 4.0

Published Online: 24-11-2021

Copyright Statement:  Copyright © 2021; Jaypee Brothers Medical Publishers (P) Ltd.


Abstract

Aim and objective: Over the years, treatment for chronic periodontitis is changing owing to an improved understanding of the pathogenesis of the periodontal disease. Tissue invasive properties of periodontal pathogens have necessitated the use of antimicrobial agents as an adjunct to mechanical plaque control in the treatment of periodontitis. Hence, the study aimed to evaluate the efficacy of ofloxacin–ornidazole combination therapy as an adjunct to scaling and root planing in the treatment of generalized chronic periodontitis. Materials and methods: A total of 40 study participants, aged from 25 to 55 years, with generalized chronic periodontitis were selected. They were randomly divided into two groups—Group I: receiving scaling and root planing along with ofloxacin–ornidazole combination therapy and group II: receiving scaling and root planing. Gingival index (GI), sulcular bleeding index (SBI), and probing pocket depth (PPD) scores were recorded at baseline, 14th day, and after 1 month. Results: Both the groups showed a reduction in GI scores, SBI scores, and mean pocket probing depth from baseline to 14th day and 1 month. However, the improvement in scores was better in a group with the ofloxacin–ornidazole combination, than the group with scaling and root planing alone. The intergroup comparison of the gingival indices, SBI, and mean pocket probing depth at baseline, 14th day, and 1 month have shown the statistically significant difference. Conclusion: It can be concluded that ofloxacin–ornidazole combination therapy is well tolerated by the patients, safe, favorable patient compliance, and proved to be effective in patients with generalized chronic periodontitis when used as an adjunct to mechanical plaque control. Clinical significance: Ofloxacin–ornidazole combination can be used as an adjuvant in the treatment of generalized chronic periodontitis.


PDF Share
  1. Socransky SS, Haffajee AD. Periodontal microbial ecology. Periodontol 2000 2005;38(1):135–187. DOI: 10.1111/j.1600-0757.2005.00107.x.
  2. Boid A, Muglikar S, Hegde R. A comparative evaluation of systemic azithromycin and ornidazole - ofloxacin combination as an adjunct to scaling and root planing in the treatment of chronic generalised periodontitis. Dentistry 2015;5(07):309. DOI: 10.4172/2161-1122.1000309.
  3. Walters J, Pin-Chuang L. Should antibiotics be prescribed to treat chronic periodontitis? Dent Clin N Am 2015;59(4):919–933. DOI: 10.1016/j.cden.2015.06.011.
  4. Bragd L, Dahlen G, Wikstrom M, et al. The capability of Actinobacillus actinomycetem comitans, Bacteroides gingivalis and Bacteroides intermedius to indicate progressive periodontitis; a retrospective study. J Clin Periodontol 1987;14(2):95–99. DOI: 10.1111/j.1600-051x.1987.tb00949.x.
  5. Zandbergen D, Slot D, Cobb C, et al. The clinical effect of scaling and root planing and the concomitant administration of systemic amoxicillin and metronidazole: a systematic review. J Periodontol 2013;84(3):332–351. DOI: 10.1902/jop.2012.120040.
  6. Mombelli A, Gusbertil FA, Lang NP. Treatment of recurrent periodontal disease by root planing and ornidazole. J Clin Periodontol 1989;16(1):38–45. DOI: 10.1111/j.1600-051x.1989.tb01610.x.
  7. Wolfson JS, Hooper DC. Comparative pharmacokinetics of ofloxacin and ciprofloxacin. Am J Med 1989;87(6C):315–320.
  8. Patil V, Mali R, Mali A. Systemic anti-microbial agents used in periodontal therapy. J Indian Soc Periodontol 2013;17(2):162–168. DOI: 10.4103/0972-124X.113063.
  9. Loe H, Silness J. Periodontal disease in pregnancy. I. Prevalence and severity. Acta Odontol Scand 1963;21(6):533–551. DOI: 10.3109/00016356309011240.
  10. Carter HG, Barnes GP. The gingival bleeding index. J Clin Periodontol 1974;45(11):801–805. DOI: 10.1902/jop.1974.45.11.801.
  11. Singh S, Vandana KL. Periodontal measurements: a dilemma. Indian J Multidiscip Dent 2018;8:17–20.
  12. Badersten A, Nilvéus R, Egelberg J. Effect of nonsurgical periodontal therapy. I. Moderately advanced periodontitis. J Clin Periodontol 1981;8(1):57–72. DOI: 10.1111/j.1600-051x.1981.tb02024.x.
  13. Brayer WK, Mellonig JT, Dunlap RM. Scaling and root planing effectiveness: the effect of root surface access and operator experience. J Periodontol 1989;60(1):67–72. DOI: 10.1902/jop.1989.60.1.67.
  14. Herrera D, Sanz M, Jepsen S. A systematic review on the effect of systemic antimicrobials as an adjunct to scaling and root planing in periodontitis patients. J Clin Periodontol 2002;29:136–159. DOI: 10.1034/j.1600-051x.29.s3.8.x.
  15. Haffajee AD, Socransky SS, Gunsolley JC. Systemic anti-infective periodontal therapy: a systematic review. Ann Periodontol 2003;8(1):115–181. DOI: 10.1902/annals.2003.8.1.115.
  16. Rams TE, Degener JE, van Winkelhoff AJ. Antibiotic resistance in human chronic periodontitis microbiota. J Periodontol 2014;85(1):160–169. DOI: 10.1902/jop.2013.130142.
  17. Dupin C, Tamanai-Shacoori Z, Ehrmann E. Oral gram-negative anaerobic bacilli as a reservoir of b-lactam resistance genes facilitating infections with multiresistant bacteria. Int J Antimicrob Agents 2015;45(2):99–105. DOI: 10.1016/j.ijantimicag.2014. 10.003.
  18. Walker CB, Gordon JM, Magnusson I, et al. A role for antibiotics in the treatment of refractory periodontitis. J Periodontol 1993;64(8s):772–781. DOI: 10.1902/jop.1993.64.8s.772.
  19. Rams TE, Slots J. Antibiotics in periodontal therapy: an update. Compendium 1992;13(12):1130–1134.
  20. Tanner A, Maiden MF, Paster BJ. The impact of 16S ribosomal RNA based phylogeny on the taxonomy of oral bacteria. Periodontol 2000 1994;5(1):26–51. DOI: 10.1111/j.1600-0757.1994.tb00017.x.
  21. Miyake Y, Onoe T, Sagawa H, et al. In vitro antibacterial activity of ofloxacin against periodontal disease-associated bacteria. J Periodont Res 1988;23(3):222–223. DOI: 10.1111/j.1600-0765.1988.tb01361.x.
  22. Higashi K, Seike M, Mitani Y, et al. Concentration of ofloxacin in human gingival crevicular fluid after oral administration of tarivid. J Periodont Res 1989;24(6):409–411. DOI: 10.1111/j.1600-0765.1989.tb00890.x.
  23. Hooper DC, Wolfson JS. The fluoroquinolones; pharmacology, clinical uses, and toxicities in humans. Antimicrob Agents Chemother 1985;28(5):716–721. DOI: 10.1128/AAC.28.5.716.
  24. Schwartz DE, Jeunet F. Comparative pharmacokinetic studies of ornidazole and metronidazole in man. Chemotherapy 1976;22(1):19–29. DOI: 10.1159/000221906.
  25. Ellie JC, Vera LS. Comparative susceptibility of anaerobic bacteria to metronidazole and ornidazole. Anti Microbial Agents Chemother 1978;14(4):609–613. DOI: 10.1128/AAC.14.4.609.
  26. Pradeep AR, Kalra N, Priyanka N, et al. Microbiological outcomes of systemic ornidazole use in chronic periodontitis. Part II. J Int Acad Periodontol 2012;14(2):50–54.
  27. Prathiba S, Mahesh Kumar PA. Comparative study of the combination of drugs -amoxicillin with metronidazole and ofloxacin with ornidazole in the treatment of dentoalveolar abscess. Oral Health Case Rep 2018;4:143–148.
  28. Eisen SA, Miller DK, Woodward RS, et al. The effect of prescribed daily dose frequency on patient medication compliance. Archi Int Med 1990;150(9):1881–1884. DOI: 10.1001/archinte.1990.00390200073014.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.